Patents buttress and backstop growth for medical technology (medtech) companies, period. This is especially so for early-stage ventures staking their claim in the medtech ecosystem. A strategic patent portfolio is

Continue Reading Mind the gap: Strengthen your patent portfolio with a white space analysis

David J. Dykeman, co-managing shareholder of global law firm Greenberg Traurig, LLP’s Boston office and co-chair of the firm’s global Life Sciences & Medical Technology Group, was featured
Continue Reading David Dykeman Featured on Product Success Podcast: Quality and Medical Devices

From floating infrastructure to biohacking, floating solar farms to AgTech, projects that are first of their kind bring with them exciting opportunities, but also unique legal complexities. In this recent
Continue Reading Maneuvering ‘Unicorns’ – Opportunities and Risks of Unprecedented Projects


Continue Reading Selecting, Clearing, and Protecting Your IP–a Top Priority for Startups, StartupSac

Most of us know that DATA, the beloved android from Star Trek, The Next Generation, is an artificial intelligence (AI) life form from the distant future with a high capacity to problem solve and innovate. But, if DATA were present today and invented a new technology, could he be an inventor on a patent for his invention?

The question of whether AI can legally be an inventor on a patent was recently addressed by the European Patent Office (EPO) and The United Kingdom Intellectual Property Office (UKIPO). The same question is still being evaluated by U.S. Patent and Trademark Office (USPTO) along with solicitation for comments to the patent community.
Continue Reading Could Star Trek’s DATA Be a Patent Inventor?